← Back to Search

Memory Training for Breast Cancer Survivors

N/A

Waitlist Available

Led By Elizabeth Ryan, PhD

Research Sponsored by Memorial Sloan Kettering Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

No evidence of disease at time of screening

Stage I, II, III breast cancer as noted in pathology reports or by clinician judgement

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 years

Awards & highlights

Study Summary

This trial is testing a memory training program for breast cancer survivors who have problems with memory after receiving chemotherapy.

Who is the study for?

This trial is for female breast cancer survivors aged 18-69 who've had chemotherapy 1-10 years ago and are currently disease-free. They must speak English, have basic computer skills, internet access, and show memory problems on specific tests. Excluded are those with significant past brain injury or cognitive issues from other conditions.Check my eligibility

What is being tested?

The study evaluates a memory training program called Cogmed Working Memory Training to see if it improves memory and attention in breast cancer survivors post-chemotherapy. Participants will use either the standard software or a less challenging version randomly assigned.See study design

What are the potential side effects?

Since this intervention involves cognitive exercises using software, side effects may be minimal but could include eye strain, headache, or frustration due to the difficulty of tasks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My current tests show no signs of cancer.

Select...

My breast cancer is at stage I, II, or III according to my doctor or pathology report.

Select...

I am between 18 and 69 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Determine the efficacy of working memory training

Secondary outcome measures

Investigate whether breast cancer survivors perceive functional improvement following working memory training.

Test whether or not working memory training in breast cancer survivors is associated with greater gains in the software's "Improvement Index".

Trial Design

2Treatment groups

Experimental Treatment

Group I: Collateral sourceExperimental Treatment1 Intervention

Participants from both groups will be asked to complete two follow up neurocognitive assessments face to face at MSKCC. The first will be completed within 1-4 weeks after completing the memory training and the second will take place 3-4 months after completing the memory training. Collateral sources will be contacted at these same points to complete their brief assessments as well to test for maintenance of the treatment effect.

Group II: Breast cancer survivorsExperimental Treatment1 Intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Cogmed Working Memory Training Program

2008

N/A

~10

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

MARTELL FOUNDATIONUNKNOWN

Memorial Sloan Kettering Cancer CenterLead Sponsor

1,933 Previous Clinical Trials

585,560 Total Patients Enrolled

202 Trials studying Breast Cancer

81,077 Patients Enrolled for Breast Cancer

Elizabeth Ryan, PhDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center

3 Previous Clinical Trials

121 Total Patients Enrolled

1 Trials studying Breast Cancer

2 Patients Enrolled for Breast Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities to join this clinical research project at present?

"The clinical trial in question, which was initially published on the 1st of August 2010 and last updated on September 1st 2022 is no longer accepting new patients. Nevertheless, 2603 other trials are currently seeking participants."

Answered by AI

Do the prerequisites for this clinical trial permit me to join?

"This clinical trial is seeking 60 female breast cancer survivors aged 18 to 69 who have undergone chemotherapy within the past 10 years. Additional requirements include demonstrating cognitive impairment relative to normative data, basic computer literacy, as well as being capable of uploading results online; for those without adequate access a laptop will be loaned out by the study. Furthermore, participants with tics are still eligible but should be aware that their symptoms may worsen during treatment."

Answered by AI

Does this research program enroll adults that exceed 35 years of age?

"This clinical trial is looking for participants aged between 18 to 69. For those under the age of 18, there are 74 available studies and 2508 existent trials that cater to individuals over 65 years old."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Rehabilitation of Cognitive Changes in Breast Cancer Survivors

2010. "Rehabilitation of Cognitive Changes in Breast Cancer Survivors". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01182506.